The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol

10 Moments That Changed HIV Care This Year

December 13, 2013


TAF Re-Introduction

TAF Re-Introduction

It's the Viread (tenofovir) you know and love -- only better!

Viread, one of the most widely used HIV drugs in the U.S., is a component of the once-a-day pills Atripla and Truvada (tenofovir/FTC). It's been around a long time -- since 2001, matter of fact. And although it's generally viewed as one of our "friendlier" HIV medications in terms of side effects, it's far from perfect: Over the years, it's been associated with a number of health issues, particularly bone loss and kidney damage, that can make it a challenge to use for people who are already predisposed to those problems.

This year, we learned about encouraging data regarding a new-and-improved form of Viread called tenofovir alafenamide fumarate, or TAF. Doctors have been buzzing about this drug for a while, but studies in 2013 have re-introduced TAF into the conversation, as their data are beginning to show just how much better its side-effect profile appears to be compared to the "old" Viread.

Read the full story >>

Related Stories

2013 Year in Review: Features and News

This article was provided by


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: